Mark Newman, Author at Endocrine News

Pushing Boundaries: Q&A with Christopher B. Newgard, PhD

Fresh from receiving his 2020 Laureate Award for Outstanding Innovation, Christopher B. Newgard, PhD, discusses how collaboration has shaped his research and why he focuses on metabolomics to unlock the mysteries of cardiometabolic diseases. Christopher B. Newgard, PhD, does not hesitate to give credit to the many mentors and colleagues who have inspired his...

Lab Notes
- Your Laboratory

Bare Benches: Research During the COVID-19 Outbreak

As the COVID-19 virus has spread around the world, more and more people are told to work from home. That includes scientists, researchers, lab techs, PhD students, and others who have had to leave the bench behind. Endocrine News reached out to researchers and basic scientists to see how life in their labs has changed,...

Viral Load: A Look at One Endocrinologist’s Practice During the COVID-19 Crisis

Via an online video conference with Endocrine News, Mihail “Misha” Zilbermint, MD, discusses how the COVID-19 virus has changed the way he practices medicine in a hospital setting, and how his approach to treating patients may be changed forever. One of the common terms that has been used to describe everything from the way...

Diabetes News and Research

Revised ADA Guidelines Include SGLT2 Inhibitors for Type 2 Diabetes Patients

SGLT2 inhibitors were designed to lower glucose, but clinical trials uncovered unexpected cardiovascular and renal benefits. Updated guidelines from the American Diabetes Association now recommends SGLT2 inhibitors in type 2 diabetes patients to lower glucose. The evidence is clear that SGLT2 inhibitors should be added to the drug regimen of many type 2 diabetes patients,...

Embracing Authenticity: Celebrating 25 Years of Diversity & Inclusion

25Years_Diversity_Logo_WhiteBackgroundOnly

Spring 2020 marks a quarter century of the Endocrine Society’s diversity initiatives. To mark this momentous occasion, Endocrine News spoke with members whose careers have been enhanced by their involvement in the Society’s diversity program. As the Endocrine Society’s Committee on Diversity and Inclusion (CoDI) celebrates its 25th anniversary this year, past and current members...

Clinical

Trump Administration Announces New Plan to Cap Insulin Costs in Medicare

High drug prices have been a focus of Congress and the Trump Administration for the past year, with insulin becoming the prime example of the negative impact increasing drug prices are having on patients. The Endocrine Society has made addressing the high cost of insulin a priority for the past three years. We have urged...

Advocacy
- Research

Endocrine Society Researcher Hill Day Advocates for More NIH Funding, Special Diabetes Reauthorization

On March 10, a small but mighty group of Endocrine Society members came to Washington D.C., to meet with their congressional delegations. Despite a number of other priorities requiring the attention of Congress, the federal appropriations process for FY 2021 must move forward and this is the time to influence decisions about funding. We used...

Bone and Mineral

Bones of Contention: The Unintended Effects of Cancer Therapy

Therapies that can extend the life of cancer patients often have a negative impact on the skeleton, especially in those being treated for hormone-sensitive cancers. Evidence shows improvements in bone health when bisphosphonates and denosumab are administered. Patients diagnosed with cancer are living longer, with some unanticipated ramifications. According to Facts & Figures 2018, published...